Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.
European journal of haematology(2023)
Abstract
De novo ITP is a rare complication of COVID-19 vaccination, and corresponding reports belong to mRNA-based and adenovirus vector-based vaccines, in order of frequency. This frequency pattern may be related to the scale of administration of individual vaccines and their potency in inducing autoimmunity. The more the COVID-19 vaccine is potent to induce antigenic challenge, the shorter the lag time would be. Most patients had a benign course and responded to typical treatments of primary ITP.
MoreTranslated text
Key words
COVID-19,SARS-CoV-2,idiopathic thrombocytopenic purpura,immune thrombocytopenia,platelet,vaccine
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined